Sanctuary Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.27M Sell
41,660
-32,609
-44% -$1.59M 0.01% 991
2026
Q1
$3.19M Buy
74,269
+7,645
+11% +$329K 0.02% 718
2025
Q4
$2.92M Buy
66,624
+35,713
+116% +$1.48M 0.02% 739
2025
Q3
$1.28M Buy
30,911
+14,794
+92% +$595K 0.01% 1147
2025
Q2
$710K Sell
16,117
-20,808
-56% -$832K ﹤0.01% 1409
2025
Q1
$1.36M Sell
36,925
-34,519
-48% -$1.23M 0.01% 977
2024
Q4
$2.35M Buy
71,444
+32,183
+82% +$1.04M 0.01% 792
2024
Q3
$1.4M Buy
39,261
+11,757
+43% +$292K 0.01% 1081
2024
Q2
$652K Buy
+27,504
New +$610K ﹤0.01% 1458

Other funds holding EXEL

Sanctuary Advisors's EXEL Position: Q2 2026 in Review

Sanctuary Advisors reduced its Exelixis (EXEL) stake by 44% in Q2 2026, selling an estimated $1.59M and leaving 41,660 shares worth $2.27M. The position accounts for 0.01% of the portfolio, ranked #991.

Sanctuary Advisors first reported a position in EXEL in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.19M in Q1 2026. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Sanctuary Advisors held 41,660 shares of Exelixis worth $2.27M as of Q2 2026.
  • Sanctuary Advisors sold 32,609 Exelixis shares in Q2 2026, an estimated $1.59M.
  • Exelixis made up 0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #991 holding.
  • Sanctuary Advisors first reported a position in Exelixis in Q2 2024 and has held it in 9 quarters since.
  • Sanctuary Advisors's Exelixis position peaked at $3.19M in Q1 2026.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.